|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation, amortization, and impairment | |||||
| Russia and Ukraine impairment | |||||
| Net periodic benefit cost | |||||
| Amortization of debt discount and deferred financing costs | |||||
| Net gain on disposal of property, plant, and equipment | |||||
| Net gain on disposal of businesses and investments | |||||
| Equity in (income)/loss of affiliated companies | |||||
| Net foreign exchange loss | |||||
| Share-based compensation | |||||
| Inventory step-up amortization | |||||
| Other, net | |||||
| Loss from highly inflationary accounting for Argentine subsidiaries | |||||
| Deferred income taxes, net | |||||
| Dividends received from affiliated companies | |||||
| Changes in operating assets and liabilities, excluding effect of acquisitions, divestitures, and currency: | |||||
| Trade receivables | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Trade payables | |||||
| Other current liabilities | |||||
| Accrued employee costs | |||||
| Employee benefit obligations | |||||
| Other, net | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Issuance of loans to affiliated companies and other | |||||
| Investments in affiliated companies and other | |||||
| Business acquisitions | |||||
| Purchase of property, plant, and equipment, and other intangible assets | |||||
| Proceeds from divestitures, net of cash divested | |||||
| Proceeds from sale of affiliated companies and other investments | |||||
| Proceeds from sales of property, plant, and equipment, and other intangible assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from exercise of options | |||||
| Purchase of treasury shares and tax withholdings for share-based incentive plans | |||||
| Purchase of non-controlling interest | |||||
| Proceeds from issuance of long-term debt | |||||
| Repayment of long-term debt | |||||
| Financing-related transaction fees | |||||
| Net borrowing/(repayment) of commercial paper | |||||
| Net borrowing/(repayment) of short-term debt | |||||
| Repayment of lease liabilities | |||||
| Share buyback/cancellations | |||||
| Dividends paid | |||||
| Net cash (used in)/provided by financing activities | |||||
| Effect of exchange rates on cash and cash equivalents | |||||
| Cash and cash equivalents classified as held for sale | |||||
| Net increase/(decrease) in cash and cash equivalents | |||||
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | |||||
| Cash and cash equivalents balance at beginning of the fiscal year | |||||
| Cash and cash equivalents balance at end of the fiscal year |
Loading...